27051274|t|Role of glycogen synthase kinase-3beta inhibitor AZD1080 in ovarian cancer.
27051274|a|BACKGROUND: Glycogen synthase kinase-3beta (GSK-3beta) is a multifunctional serine/threonine kinase that plays an important role in cancer tumorigenesis and progression. We investigated the role of the GSK-3beta inhibitor AZD1080 in ovarian cancer cell lines. METHODS: A2780 and OVCAR3 ovarian cancer cell lines were exposed to AZD1080, after which cell proliferation, cell cycle, invasion, and migration assays were performed. Phalloidin staining was used to observe lamellipodia formation. Reverse transcription polymerase chain reaction and Western blot were used to assess the respective mRNA and protein expression levels of GSK-3beta, CDK2, CDK1, cyclin D1, matrix metalloproteinase-9 (MMP9), and Bcl-xL. RESULTS: AZD1080 exposure suppressed ovarian cancer cell proliferation, invasion, migration, and lamellipodia formation, and induced G1 arrest, which was concentration dependent. AZD1080 also significantly downregulated GSK-3beta, CDK2, CDK1, cyclin D1, MMP9, and Bcl-xL expression at both mRNA and protein levels. CONCLUSION: Taken together, our results demonstrate that the GSK-3beta inhibitor AZD1080 suppresses ovarian cancer development and therefore may indicate a new direction for ovarian cancer treatment.
27051274	8	38	glycogen synthase kinase-3beta	Gene	2932
27051274	49	56	AZD1080	Chemical	MESH:C581774
27051274	60	74	ovarian cancer	Disease	MESH:D010051
27051274	88	118	Glycogen synthase kinase-3beta	Gene	2932
27051274	120	129	GSK-3beta	Gene	2932
27051274	208	214	cancer	Disease	MESH:D009369
27051274	278	287	GSK-3beta	Gene	2932
27051274	298	305	AZD1080	Chemical	MESH:C581774
27051274	309	323	ovarian cancer	Disease	MESH:D010051
27051274	345	350	A2780	CellLine	CVCL:0134
27051274	355	361	OVCAR3	CellLine	CVCL:0465
27051274	362	376	ovarian cancer	Disease	MESH:D010051
27051274	404	411	AZD1080	Chemical	MESH:C581774
27051274	504	514	Phalloidin	Chemical	MESH:D010590
27051274	706	715	GSK-3beta	Gene	2932
27051274	717	721	CDK2	Gene	1017
27051274	723	727	CDK1	Gene	983
27051274	729	738	cyclin D1	Gene	595
27051274	740	766	matrix metalloproteinase-9	Gene	4318
27051274	768	772	MMP9	Gene	4318
27051274	779	786	Bcl-xL.	Gene	598
27051274	796	803	AZD1080	Chemical	MESH:C581774
27051274	824	838	ovarian cancer	Disease	MESH:D010051
27051274	966	973	AZD1080	Chemical	MESH:C581774
27051274	1007	1016	GSK-3beta	Gene	2932
27051274	1018	1022	CDK2	Gene	1017
27051274	1024	1028	CDK1	Gene	983
27051274	1030	1039	cyclin D1	Gene	595
27051274	1041	1045	MMP9	Gene	4318
27051274	1051	1057	Bcl-xL	Gene	598
27051274	1163	1172	GSK-3beta	Gene	2932
27051274	1183	1190	AZD1080	Chemical	MESH:C581774
27051274	1202	1216	ovarian cancer	Disease	MESH:D010051
27051274	1276	1290	ovarian cancer	Disease	MESH:D010051
27051274	Negative_Correlation	MESH:C581774	595
27051274	Negative_Correlation	MESH:C581774	2932
27051274	Negative_Correlation	MESH:C581774	4318
27051274	Negative_Correlation	MESH:C581774	MESH:D010051
27051274	Negative_Correlation	MESH:C581774	1017
27051274	Association	MESH:D010051	2932
27051274	Negative_Correlation	MESH:C581774	983
27051274	Negative_Correlation	MESH:C581774	598
27051274	Association	MESH:D009369	2932

